(Press-News.org) DUBLIN—A new secondary analysis of the STEP TEENS trial presented at this year’s European Congress on Obesity (ECO 2023, Dublin 17-20 May) and published in the journal Obesity shows that almost half (45%) of the adolescents assigned to semaglutide in the trial managed to lose enough weight to drop below the clinical cutoff for obesity.
The study, led by Aaron S. Kelly, PhD, co-director of the Center for Pediatric Obesity Medicine at the University of Minnesota, Minneapolis, and colleagues, also showed almost three quarters (74%) moved down by at least one weight category.
The full STEP TEENS trial, published in 2022 in the New England Journal of Medicine (NEJM), showed the efficacy of semaglutide in helping adolescents lose weight. In this secondary analysis of the STEP TEENS trial, the authors examined the effect of semaglutide treatment on improvement in body mass index (BMI) categories.
Adolescents aged 12 to under 18 years with BMI in the highest 5% were included in this analysis. Participants were randomized 2:1 to once-weekly subcutaneous semaglutide 2.4 mg (n=134) or placebo (n=67) for 68 weeks; both groups received matching lifestyle counseling. The proportion of participants who achieved an improvement in BMI category from baseline to week 68 was assessed using on-treatment data.
BMI categories, based on Centers for Disease Control and Prevention BMI charts, were: normal weight (BMI ≥5th to <85th percentile); overweight (BMI ≥85th to <95th percentile); and obesity class I (OCI; BMI ≥95th percentile). Severe obesity class II (OCII) and class III (OCIII) are based on a percentage above the 95th percentile cutoff for obesity – OCII is defined as ≥20% above this cutoff and OCIII is defined as ≥40% above this cutoff.
Of 201 adolescents randomized, 62 (31%), 69 (34%) and 69 (34%) were in OCIII, OCII and OCI, respectively; only one participant (0.5%) had overweight and was excluded from this secondary analysis. At randomization, mean body weight was 107.5 kg and mean BMI was 37.0 kg/m2 (OCII).
At week 68, 74% of participants on semaglutide had an improvement of one or more BMI categories versus 19% on placebo. An improvement of ≥2 BMI categories occurred in 45% of participants treated with semaglutide versus 3% with placebo. Overall, treatment with semaglutide reduced the proportion of participants with the most severe degree of obesity (OCIII) from 37% to 14% after 68 weeks.
By week 68, a total of 45% participants in the semaglutide arm experienced a reduction in BMI below the clinical cutoff point for obesity (i.e., reached normal weight or overweight) versus 12% of participants in the placebo arm.
The authors concluded, “Once-weekly semaglutide was associated with clinically meaningful improvements in BMI categories versus PBO across all BMI classes in adolescents with obesity.”
“These results underscore the high degree of clinical effectiveness of semaglutide in adolescents with obesity,” said Kelly. “In a practical sense, we see that semaglutide reduced weight to a level below what is defined as clinical obesity in nearly 50% of the teens in our trial, which is historically unprecedented with treatments other than bariatric surgery.”
Aaron S. Kelly, PhD, University of Minnesota Medical School, Minneapolis. Please e-mail to arrange an interview. kelly105@umn.edu Twitter: @AaronKelly_PhD
Note to Editors:
Kelly will present this study at an embargoed press conference at 1200H Noon Dublin Time on Wednesday, May 17, 2023. An audio of the embargoed press conference plus a link to the slide presentation will be circulated after the press conference.
This press release is based on oral presentation AD06.04 at the European Congress on Obesity, and the study will be published at the above embargo time in the journal Obesity. The material has also been peer reviewed by the congress selection committee.
For a link to full embargoed paper (including all conflict of interest disclosures), click here
For a post-embargo paper link to use in your stories, click here
For STEP TEENS trial published in NEJM in 2022, click here
# # #
The Obesity Society (TOS) is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects. Combining the perspective of researchers, clinicians, policymakers and patients, TOS promotes innovative research, education and evidence-based clinical care to improve the health and well-being of all people with obesity. For more information, visit www.obesity.org.
END
The number of women and non-white people in academic medicine and biomedical research continues to increase, yet the proportion of women among Lasker Award recipients has not changed in more than 70 years, finds a study published by The BMJ today.
And only one non-white woman was identified as having received a Lasker Award over the course of seven decades, the findings show.
The researchers say these results are difficult to reconcile given the ever increasing number of qualified scientists from diverse backgrounds, and they call for more transparency around ...
Most high income countries, including the UK, do not have a national prostate cancer screening programme, but instead allow men without symptoms to get a prostate-specific antigen (PSA) test if they wish, after talking to their doctor.
But experts writing in The BMJ today argue that these shared decision policies have led to high rates of PSA testing and clear medical harm, with minimal benefit and inequity.
Andrew Vickers and an international group of colleagues argue that high income countries should either implement a comprehensive risk based approach ...
Scientists say tonsil removal is both clinically and cost effective for adults who get recurrent severe sore throats.
The biggest study of its kind, carried out by Newcastle University, revealed that patients who had a tonsillectomy had 50% less sore throats over two years, compared to patients who did not undergo tonsillectomy. Publishing today (17 May) in The Lancet, the study was funded by the National Institute for Health and Care Research (NIHR).
Experts also found that a tonsillectomy for those aged 16 years and over was cost effective ...
This collaborative study between researchers in the UK and Australia is a huge step towards aligning outcome reporting with patient priorities in advanced cancer settings. The study, published in the journal eClinical Medicine (The Lancet Discovery Science), details the development, testing and analysis of this design-specific measure to assess quality of life in patients with recurrent rectal cancer, regardless of treatment intent.
This new measure – called the LRRC–QoL – consists of nine multi-item scales (healthcare services, psychological ...
Substantive changes are needed to improve patient safety in prisons, according to a new study published by the Journal of the Royal Society of Medicine (JRSM) and funded by the National Institute for Health and Care Research (NIHR). Practical changes such as timely access to healthcare services and better processes to mitigate medication-related harm should be prioritised, according to the researchers.
In the first nationwide analysis of patient safety incidents in prisons in England, researchers found that security, staffing constraints and the high turnover of prisoners are among the main barriers to the safe delivery of healthcare ...
As we age, our muscles start to waste. Called sarcopenia, it happens to us all, yet no one has ever understood why and how it happens. Now new research from the Australian Regenerative Medicine Institute (ARMI) at Monash University has used a surprising animal model – the African killifish – to reveal that towards the end of life, our muscles actually reverse to an “early-life” state, slowing mortality. This finding may provide a clue to slowing, halting or even reversing age-related loss of muscle mass and strength.
The research, published ...
UCL Press Release
Under embargo until Thursday 18th May, 01:00 UK time / Wednesday 17th May, 20:00 Eastern US time
Peer reviewed | Literature review | People
One of the world’s largest fundamentalist Christian education groups is teaching its students climate change denial as fact, and still presents the theory of evolution as an ‘absurd and discredited’ conspiracy theory, finds a report by UCL researchers.
Accelerated Christian Education (ACE) is one of the world’s biggest providers of creationist science materials, consisting of reading programmes and a core ...
For the first time, astronomers have observed radio waves emitted by a Type Ia supernova, a type of explosion originating from a white dwarf star. This provides important clues to understand how white dwarfs explode.
A Type Ia (One-A) supernova is the nuclear explosion of a white dwarf star. This type of supernova is well known; these supernovae are used by astronomers to measure cosmological distances and the expansion of the Universe. But the explosion mechanism of Type Ia supernovae is not well understood. Solitary white dwarfs don’t explode, so it is thought that mass accretion from a neighboring companion ...
Kyoto, Japan -- Purple is a color that has historically been associated with nobility around the world. Japan is no exception. However, its distinct murasaki hue is threatened as the native gromwell plant -- synonymous with murasaki -- has become an endangered species.
Disease and cross-breeding with non-native species are partly to blame for murasaki's growing demise.
Now, a research group including Kyoto University, is leading a movement to raise awareness of gromwell's importance in preserving ...
A new study of more than 50,000 US adolescents across the country indicates that vaping nicotine is strongly linked with an increased likelihood of high levels use of binge drinking and cannabis usage.
The findings, published today in the peer-reviewed journal Substance Use and Misuse, will add to growing public health concerns about the increased popularity of electronic cigarette (or ‘vaping’) use among young people.
“While the overall health risks of vaping are lower than smoking, electronic cigarettes are still harmful to adolescents and warrant ongoing ...
